NEVRO CORP. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 32 rows in 2017. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2017-12-21: Reporting owner DEMANE MICHAEL F; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2017-12-18: Reporting owner Rashid Kashif; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-12-12: Reporting owner Alecxih James; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2017-11-14: Reporting owner Schmitz Patrick; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2017-12-21 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −41,572 0 owned after | $3.60 exercise price | 2017-12-22 | |
| 2017-12-18 | Rashid Kashif Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $70.86 exercise price | 2017-12-20 | |
| 2017-12-12 | Alecxih James Officer (Vice President, Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $66.26 exercise price | 2017-12-14 | |
| 2017-11-14 | Schmitz Patrick Officer (Vice President, Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,000 13,000 owned after | $76.81 exercise price | 2017-11-16 | |
| 2017-11-14 | Christoforou Christofer Officer (VP, Research & Development) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,000 13,000 owned after | $76.81 exercise price | 2017-11-16 | |
| 2017-11-14 | Alleavitch Doug Officer (VP, Quality) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,000 13,000 owned after | $76.81 exercise price | 2017-11-16 | |
| 2017-11-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,000 26,000 owned after | $76.81 exercise price | 2017-11-16 | |
| 2017-11-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,000 35,463 owned after | $18.00 exercise price | 2017-11-16 | |
| 2017-11-14 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | +70,500 70,500 owned after | $76.81 exercise price | 2017-11-16 | |
| 2017-11-09 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 18,404 owned after | $1.44 exercise price | 2017-11-13 | |
| 2017-08-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −652 43,894 owned after | $3.60 exercise price | 2017-08-16 | |
| 2017-08-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,144 36,286 owned after | $3.60 exercise price | 2017-08-16 | |
| 2017-08-14 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −204 42,463 owned after | $18.00 exercise price | 2017-08-16 | |
| 2017-05-25 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | Vale Brad Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | Behbahani Ali Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | McCormick Shawn Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | JAEGER WILFRED E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | Fischer Frank M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-25 | Earnhardt Lisa D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,545 3,545 owned after | $74.07 exercise price | 2017-05-30 | |
| 2017-05-15 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 44,546 owned after | $3.60 exercise price | 2017-05-16 | |
| 2017-05-09 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 22,404 owned after | $1.44 exercise price | 2017-05-11 | |
| 2017-05-01 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 65,051 owned after | $3.60 exercise price | 2017-05-03 | |
| 2017-04-04 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 37,108 owned after | $3.60 exercise price | 2017-04-05 | |
| 2017-03-28 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,929 41,572 owned after | $3.60 exercise price | 2017-03-30 | |
| 2017-03-28 | DEMANE MICHAEL F Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −691 83,922 owned after | $18.00 exercise price | 2017-03-30 | |
| 2017-03-06 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 38,608 owned after | $3.60 exercise price | 2017-03-08 | |
| 2017-03-01 | Galligan Andrew H Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 52,046 owned after | $3.60 exercise price | 2017-03-03 | |
| 2017-02-06 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 40,108 owned after | $3.60 exercise price | 2017-02-08 | |
| 2017-01-26 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,000 41,608 owned after | $3.60 exercise price | 2017-01-30 | |
| 2017-01-04 | Enxing Michael Officer (VP of Sales) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,500 78,608 owned after | $3.60 exercise price | 2017-01-05 | |
| 2017-01-03 | Elghandour Rami Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +124,175 124,175 owned after | $75.17 exercise price | 2017-01-05 |